These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 31057017

  • 21. Association of diabetes with failure to achieve complete remission of idiopathic membranous nephropathy.
    Xie H, Li C, Wen Y, Ye W, Cai J, Li H, Li X, Li X.
    Int Urol Nephrol; 2020 Feb; 52(2):337-342. PubMed ID: 31820359
    [Abstract] [Full Text] [Related]

  • 22. Long-term outcome and prognostic factors of idiopathic membranous nephropathy in the Chinese population.
    Zuo K, Wu Y, Li SJ, Xu F, Zeng CH, Liu ZH.
    Clin Nephrol; 2013 Jun; 79(6):445-53. PubMed ID: 23458172
    [Abstract] [Full Text] [Related]

  • 23. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A, Hill GS, Montseny JJ, Meyrier A.
    Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
    [Abstract] [Full Text] [Related]

  • 24. Clinical implications of pathological features of primary membranous nephropathy.
    Zhang XD, Cui Z, Zhang MF, Wang J, Zhang YM, Qu Z, Wang X, Huang J, Wang F, Meng LQ, Cheng XY, Wang SX, Liu G, Zhao MH.
    BMC Nephrol; 2018 Aug 28; 19(1):215. PubMed ID: 30153817
    [Abstract] [Full Text] [Related]

  • 25. Detection and clinical significance of glomerular M-type phospholipase A2 receptor in patients with idiopathic membranous nephropathy.
    Liu H, Luo W, Gong S, Ding X.
    Intern Med J; 2016 Nov 28; 46(11):1318-1322. PubMed ID: 27554390
    [Abstract] [Full Text] [Related]

  • 26. Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy.
    Hofstra JM, Deegens JK, Willems HL, Wetzels JF.
    Nephrol Dial Transplant; 2008 Aug 28; 23(8):2546-51. PubMed ID: 18308774
    [Abstract] [Full Text] [Related]

  • 27. Urinary excretion of IgG and alpha(1)-microglobulin predicts clinical course better than extent of proteinuria in membranous nephropathy.
    Bazzi C, Petrini C, Rizza V, Arrigo G, Beltrame A, Pisano L, D'Amico G.
    Am J Kidney Dis; 2001 Aug 28; 38(2):240-8. PubMed ID: 11479148
    [Abstract] [Full Text] [Related]

  • 28. Renal pathology in idiopathic membranous nephropathy: a new perspective.
    Troyanov S, Roasio L, Pandes M, Herzenberg AM, Cattran DC.
    Kidney Int; 2006 May 28; 69(9):1641-8. PubMed ID: 16572119
    [Abstract] [Full Text] [Related]

  • 29. Utility of non-HDL-C in predicting proteinuria remission of idiopathic membranous nephropathy: a retrospective cohort study.
    Dong L, Wei W, Han M, Xu G.
    Lipids Health Dis; 2021 Sep 29; 20(1):122. PubMed ID: 34587945
    [Abstract] [Full Text] [Related]

  • 30. Pathological predictors of renal outcomes in nephrotic idiopathic membranous nephropathy with decreased renal function.
    Chen Y, Tang L, Feng Z, Cao X, Sun X, Liu M, Liu S, Zhang X, Li P, Wei R, Qiu Q, Cai G, Chen X.
    J Nephrol; 2014 Jun 29; 27(3):307-16. PubMed ID: 24523071
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Clinicopathological features and prognosis of idiopathic membranous nephropathy with thyroid dysfunction.
    Wang P, Wang S, Huang B, Liu Y, Liu Y, Chen H, Zhang J.
    Front Endocrinol (Lausanne); 2023 Jun 29; 14():1133521. PubMed ID: 37008916
    [Abstract] [Full Text] [Related]

  • 33. Growth Differentiation Factor-15 as a Predictor of Idiopathic Membranous Nephropathy Progression: A Retrospective Study.
    Ham YR, Song CH, Bae HJ, Jeong JY, Yeo MK, Choi DE, Na KR, Lee KW.
    Dis Markers; 2018 Jun 29; 2018():1463940. PubMed ID: 29682097
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Outcome of Idiopathic Membranous Nephropathy: A Retrospective Study.
    Rozenberg I, Kotliroff A, Zahavi T, Benchetrit S.
    Isr Med Assoc J; 2018 Mar 29; 20(3):186-189. PubMed ID: 29527859
    [Abstract] [Full Text] [Related]

  • 37. Non-diabetic urine glucose in idiopathic membranous nephropathy.
    Liu L, Zuo K, Le W, Lu M, Liu Z, Xu W.
    Ren Fail; 2022 Dec 29; 44(1):1104-1111. PubMed ID: 35820795
    [Abstract] [Full Text] [Related]

  • 38. sPLA2-IB Level Correlates with Hyperlipidemia and the Prognosis of Idiopathic Membranous Nephropathy.
    Yang LY, Wu YS, Dai BB, Lin SH, Chen H, Li GP, Tao X, Wan JX, Pan YB.
    Curr Med Sci; 2020 Aug 29; 40(4):683-690. PubMed ID: 32862379
    [Abstract] [Full Text] [Related]

  • 39. Prognostic value of risk score and urinary markers in idiopathic membranous nephropathy.
    van den Brand JA, Hofstra JM, Wetzels JF.
    Clin J Am Soc Nephrol; 2012 Aug 29; 7(8):1242-8. PubMed ID: 22595828
    [Abstract] [Full Text] [Related]

  • 40. ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome.
    Ruggenenti P, Mosconi L, Vendramin G, Moriggi M, Remuzzi A, Sangalli F, Remuzzi G.
    Am J Kidney Dis; 2000 Mar 29; 35(3):381-91. PubMed ID: 10692263
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.